Identification of Biomarkers for Stress Vulnerability and Resilience
Launched by UNIVERSITY OF MICHIGAN · Aug 9, 2022
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to learn more about how people respond to stress. Specifically, researchers want to understand why some people are more vulnerable to stress while others are better at bouncing back from it. They aim to find biological markers—think of these as indicators in the body that can show how well someone handles stress. By identifying these markers, the study hopes to create better ways to prevent and treat stress-related issues.
If you are a new freshman student at the University of Michigan and between the ages of 18 and 25, you might be eligible to participate. However, if you have thoughts of hurting yourself, you would not be able to join. Participants in the study can expect to help contribute to important research that could lead to improved mental health support for themselves and others in the future. The trial is currently recruiting participants, so there's an opportunity to get involved!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Incoming Freshmen Students at the University of Michigan
- Exclusion Criteria:
- • Suicidal Ideation
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
Huda Akil, PhD
Principal Investigator
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials